Can we predict dangerous side effects of immunotherapy?
NCT ID NCT07527585
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find biological markers that can predict immune-related side effects in cancer patients receiving immune checkpoint inhibitor therapy. Researchers will collect data from 440 participants to build a model that forecasts these adverse events. The goal is to improve safety and personalize treatment for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE-RELATED ADVERSE EVENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single rituximab infusion tame Immunotherapy's harsh side effects?
- Cancer immunotherapy side effects under the microscope: can patients safely resume treatment?
- New drug combo shows promise in shrinking esophageal tumors before surgery
- Can two existing drugs help cancer patients ditch steroids?
- Can we predict dangerous side effects of cancer immunotherapy?
- Blood test may predict dangerous immunotherapy reactions